FDA warns of risks to newborns given Rocephin with calcium

07/5/2007 | Reuters

The FDA issued a warning to physicians that Roche Holding's Rocephin injected antibiotic poses risks to newborn babies if it is combined with calcium. The agency noted reports of fatal reactions in newborns treated for treat lower respiratory infections, urinary tract infections, gonorrhea and other infections.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Senior Scientist - Cell Engineering Group
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC